- Software and services
- Instruments
- Reagents and consumables
Veterinary Invitro Diagnostics Market size was valued at USD 4.6 billion in 2022 and expected to reach USD 9.8 billion by 2029, at a CAGR of 10.5% during the forecast period 2023-2029. Veterinary diagnostics is a critical component in the treatment and prevention of disease epidemics in animals. Various new technologies from the human diagnostics sector have been adopted for use in the veterinary field. Immunodiagnostics, clinical biochemistry, haematological, urinalysis, molecular diagnostics, and other technologies are used. Medical testing for infectious toxins and agents in the assessment of animal specimens can also be done in veterinary laboratories. Veterinary specialists must collect specimens for analysis on behalf of government employees, for the administration or care of the public health of animal owners, and scientists must collect specimens for analysis. Diagnostic labs include dedicated research centres in Molecular, Bacteriology, Medical and Diagnostic Services, Pathology, Toxicity/Dietetics, and the Virology laboratory.
Global Veterinary Invitro Diagnostics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
10.5%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Veterinary Invitro Diagnostics Market Dynamics
Veterinary In-vitro diagnostics are used for detecting infections, conditions and diseases, and also used to monitor the health status of animals and therapeutic procedures by examining the specimens like blood, tissue, urine, stools and other bodily fluids derived from body of the animal. Various technologies are incorporated in Invitro diagnostics such as micro array techniques, mass spectrometry, polymerase chain reaction and sequencing technology are used for testing the sample preparation. Factors such as upsurge of pet adoption, increase in zoonotic diseases, rise in Veterinary healthcare awareness in pet owners are driving the market globally. Furthermore, increase in healthcare expenditure on animals, technological advancements in veterinary diagnostics also propels the growth for market globally. However, lack of awareness, high cost of the tests, stringent regulatory framework may hamper the growth of the market globally.
North-America Got Significant Share of
Veterinary Invitro Diagnostics Market Regional Analysis
Geographically, the Veterinary In-vitro diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. Veterinary In vitro Diagnostics Market is dominated by North America followed by Europe due to the increasing practitioners in veterinary and well established veterinary healthcare in those regions. Due to the increase in adoption of animals, growing health concerns about the pets and humanization of animals are the factors which are supporting the Asia Pacific regions such as India and China to show significant growth in the Market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The veterinary In-vitro diagnostics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Veterinary Invitro Diagnostics Market Segmentation
By Type
By Products
- Blood testing
- Immunodiagnostics
- Tissue diagnostics
- Molecular diagnostics
- Chemical chemistry
By Disease Condition
- Immune system disorders
- Infectious disease
- Neurological disorders
- Cancer
- Nephrological diseases
- Gastrointestinal disorders
- Others
By Animal Type
- Ruminants
- Equine
- Canine
- Feline
- Swine
- Others
Frequently Asked Questions
The Veterinary Invitro Diagnostics Market size was valued at USD 4.6 billion in 2022
The Veterinary Invitro Diagnostics Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Asia Pacific is the fastest-growing for Veterinary Invitro Diagnostics Market
| 1.Executive Summary |
| 2.Global Veterinary Invitro Diagnostics Market Introduction |
| 2.1.Global Veterinary Invitro Diagnostics Market - Taxonomy |
| 2.2.Global Veterinary Invitro Diagnostics Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Products |
| 2.2.3.Disease Condition |
| 2.2.4.Animal Type |
| 2.2.5.Region |
| 3.Global Veterinary Invitro Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Veterinary Invitro Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Veterinary Invitro Diagnostics Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Software and services |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Reagents and consumables |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Veterinary Invitro Diagnostics Market By Products, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Blood testing |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Immunodiagnostics |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Tissue diagnostics |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Molecular diagnostics |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Chemical chemistry |
| 6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Veterinary Invitro Diagnostics Market By Disease Condition, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Immune system disorders |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Infectious disease |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Neurological disorders |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Cancer |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Nephrological diseases |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Gastrointestinal disorders |
| 7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8.Global Veterinary Invitro Diagnostics Market By Animal Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Ruminants |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Equine |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Canine |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Feline |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Swine |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Others |
| 8.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.6.3. Market Opportunity Analysis |
| 9.Global Veterinary Invitro Diagnostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Veterinary Invitro Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Software and services |
| 10.1.2.Instruments |
| 10.1.3.Reagents and consumables |
| 10.2. Products Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Blood testing |
| 10.2.2.Immunodiagnostics |
| 10.2.3.Tissue diagnostics |
| 10.2.4.Molecular diagnostics |
| 10.2.5.Chemical chemistry |
| 10.3. Disease Condition Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Immune system disorders |
| 10.3.2.Infectious disease |
| 10.3.3.Neurological disorders |
| 10.3.4.Cancer |
| 10.3.5.Nephrological diseases |
| 10.3.6.Gastrointestinal disorders |
| 10.3.7.Others |
| 10.4. Animal Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Ruminants |
| 10.4.2.Equine |
| 10.4.3.Canine |
| 10.4.4.Feline |
| 10.4.5.Swine |
| 10.4.6.Others |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Veterinary Invitro Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Software and services |
| 11.1.2.Instruments |
| 11.1.3.Reagents and consumables |
| 11.2. Products Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Blood testing |
| 11.2.2.Immunodiagnostics |
| 11.2.3.Tissue diagnostics |
| 11.2.4.Molecular diagnostics |
| 11.2.5.Chemical chemistry |
| 11.3. Disease Condition Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Immune system disorders |
| 11.3.2.Infectious disease |
| 11.3.3.Neurological disorders |
| 11.3.4.Cancer |
| 11.3.5.Nephrological diseases |
| 11.3.6.Gastrointestinal disorders |
| 11.3.7.Others |
| 11.4. Animal Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Ruminants |
| 11.4.2.Equine |
| 11.4.3.Canine |
| 11.4.4.Feline |
| 11.4.5.Swine |
| 11.4.6.Others |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Veterinary Invitro Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Software and services |
| 12.1.2.Instruments |
| 12.1.3.Reagents and consumables |
| 12.2. Products Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Blood testing |
| 12.2.2.Immunodiagnostics |
| 12.2.3.Tissue diagnostics |
| 12.2.4.Molecular diagnostics |
| 12.2.5.Chemical chemistry |
| 12.3. Disease Condition Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Immune system disorders |
| 12.3.2.Infectious disease |
| 12.3.3.Neurological disorders |
| 12.3.4.Cancer |
| 12.3.5.Nephrological diseases |
| 12.3.6.Gastrointestinal disorders |
| 12.3.7.Others |
| 12.4. Animal Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Ruminants |
| 12.4.2.Equine |
| 12.4.3.Canine |
| 12.4.4.Feline |
| 12.4.5.Swine |
| 12.4.6.Others |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Veterinary Invitro Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Software and services |
| 13.1.2.Instruments |
| 13.1.3.Reagents and consumables |
| 13.2. Products Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Blood testing |
| 13.2.2.Immunodiagnostics |
| 13.2.3.Tissue diagnostics |
| 13.2.4.Molecular diagnostics |
| 13.2.5.Chemical chemistry |
| 13.3. Disease Condition Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Immune system disorders |
| 13.3.2.Infectious disease |
| 13.3.3.Neurological disorders |
| 13.3.4.Cancer |
| 13.3.5.Nephrological diseases |
| 13.3.6.Gastrointestinal disorders |
| 13.3.7.Others |
| 13.4. Animal Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Ruminants |
| 13.4.2.Equine |
| 13.4.3.Canine |
| 13.4.4.Feline |
| 13.4.5.Swine |
| 13.4.6.Others |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Veterinary Invitro Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Software and services |
| 14.1.2.Instruments |
| 14.1.3.Reagents and consumables |
| 14.2. Products Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Blood testing |
| 14.2.2.Immunodiagnostics |
| 14.2.3.Tissue diagnostics |
| 14.2.4.Molecular diagnostics |
| 14.2.5.Chemical chemistry |
| 14.3. Disease Condition Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Immune system disorders |
| 14.3.2.Infectious disease |
| 14.3.3.Neurological disorders |
| 14.3.4.Cancer |
| 14.3.5.Nephrological diseases |
| 14.3.6.Gastrointestinal disorders |
| 14.3.7.Others |
| 14.4. Animal Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Ruminants |
| 14.4.2.Equine |
| 14.4.3.Canine |
| 14.4.4.Feline |
| 14.4.5.Swine |
| 14.4.6.Others |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Zoetis |
| 15.2.2.Heska Corp. |
| 15.2.3.IDEXX Laboratories Inc. |
| 15.2.4.Agrolabo S.p.A. |
| 15.2.5.IDvet |
| 15.2.6.Virbac |
| 15.2.7.Thermo Fisher Scientific Inc. |
| 15.2.8.Neogen Corp. |
| 15.2.9.Covetrus |
| 15.2.10.iM3Vet Pty Ltd |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Zoetis
- Heska Corp.
- IDEXX Laboratories Inc.
- Agrolabo S.p.A.
- IDvet
- Virbac
- Thermo Fisher Scientific Inc.
- Neogen Corp.
- Covetrus
- iM3Vet Pty Ltd